Tumor Effect Articles & Analysis: Older
50 articles found
This modification system plays a crucial role in cellular biological processes such as tumor metabolism and immune regulation while also shaping the tumor microenvironment through control of translation efficiency and mitochondrial function along with tRNA fragment generation. ...
Additionally, PEGylation protects proteins from aggregation and denaturation, improving shelf-life. 4. Enhanced Tumor Targeting (Passive Accumulation) In oncology, PEGylated drugs benefit from the Enhanced Permeability and Retention (EPR) effect, where leaky tumor vasculature allows selective accumulation of macromolecules. ...
Glycoprotein 1b on platelet surfaces assists tissue regeneration and injury repair by attaching to von Willebrand factor (vWF) and collagen from damaged blood vessels and when activated P-selectin from platelets becomes externalized it binds to PSGL-1 or CD44 on tumor cells thereby forming a defensive wall against tumor cells. These processes can offer ...
This phenomenon offers a remarkable opportunity in cancer therapy. Tumors often exhibit mutations that can be exploited for targeted treatments. ...
Breast cancer remains one of the most prevalent malignancies affecting women worldwide, necessitating innovative approaches for effective treatment and research. Among the most promising strategies in this endeavor are the use of tumor models for breast cancer and the development of customized antibody-drug conjugates (ADCs). ...
Even different tumor cells within the same tumor differ in their metabolic patterns. ...
Compared with traditional cytotoxins, ADCs have the advantages of strong targeting, less toxic side effects, etc. They can accurately target tumor cells, reduce side effects, and improve the therapeutic effect.ADC drugs are mainly composed of monoclonal antibodies, linkers, and small molecule cytotoxins. ...
Alfa Cytology, a biotech company composed of scientists, bioinformatics, and oncologists, has recently announced its pancreatic cancer vaccine development services to provide further strategies for cancer therapy research. Compared to other solid tumors, pancreatic cancer (PC) lacks effective therapy with poor outcomes. ...
Ongoing research and inventions in the field of oncology focus on the development of small molecule drug therapies for use in brain tumor resection. Small molecule drugs are being developed to target and effectively treat brain tumors to improve therapeutic outcomes. ...
Because nanobodies are smaller in size and have stronger tumor tissue penetration capabilities, researchers are currently applying them to ADC drugs for the treatment of solid tumors, hoping to improve the solid tumor tissue penetration effects of current ADC drugs.Nanobody StructureGenerally, the relative molecular mass of ...
Classification When the surface of the liposome is modified, the properties of the liposome can be changed to control the release of the internal drug, to achieve better targeting effect and drug efficacy. Current liposome release triggers include heat, light, pH, temperature, ultrasound, enzymes, magnetism and et al., which have been widely used in anti-tumor ...
Drugs can get dispersed throughout the body, leading to unwanted side effects. They may also be quickly degraded or eliminated before reaching their target. ...
Effectively reduce treatment costs: Compared with traditional antibodies, BsAb is highly competitive in terms of tissue penetration rate, tumor cell killing efficiency, off-target rate and clinical indications, and has significant clinical advantages. ...
CD73 Expression and Its Impact on Tumor Cells CD73 is found at higher expression levels in the majority of human solid tumors, and its presence is closely linked to tumor invasiveness and metastasis[15]. Research[16] has confirmed that the extracellular adenosine produced by CD73 on tumor cells plays a significant role in immune ...
About Tumor Suppressor Genes A tumor suppressor gene, also known as anti-onco gene, is an essential component of the body's defense against cancer. ...
Consequently, WES has become the preferred approach for comparing tumor-normal samples. Tumor Mutational Burden (TMB) Analysis using WES Tumor Mutational Burden (TMB) quantifies the number of somatic mutations per megabase (MB) of the longest transcript sequence. Although TMB shows potential as a biomarker for immunotherapy in solid ...
Classification and function Cytokines can be classified into different groups based on their functions, including: interleukin (IL), interferon (IFN), tumor necrosis factor (TNF), colony stimulating factor (CSF), chemokine family, growth factor (GF), and TGF-β family. ...
TSLP also enhances the release of TH2 cytokines and chemokines from eosinophils, mast cells, and macrophages. In addition to its indirect effects, TSLP can directly act on CD4+ T cells, aiding in their proliferation, differentiation, and response to antigens[3]. TSLP and cancer New functions of TSLP have been discovered in the induction and progression of various ...
Tumors and Blood Vessel Growth Tumor, as an abnormal mass of cells, has blood vessels of various sizes that can be seen everywhere on the surface and deep within it. ...
According to the latest data, breast cancer has overtaken lung cancer to become the most common cancer among women, and the death rate is the second highest among female tumors, seriously affecting the physical and mental health of women around the world. ...